Voyager Therapeutics Inc

Open

3.51 -2.23

Overview

Share price change

24h

Current

Min

3.52

Max

3.7

Key metrics

By Trading Economics

Income

-511K

-28M

Sales

-13M

2.6M

EPS

-0.47

Profit margin

-1,077.401

Employees

141

EBITDA

1.9M

-27M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+374.86% upside

Dividends

By Acuity

Next Earnings

4 sie 2026

Market Stats

By TradingEconomics

Market Cap

-7.2M

227M

Previous open

5.74

Previous close

3.51

Voyager Therapeutics Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

29 cze 2026, 23:56 UTC

Willis Towers Watson PLC shares declined slightly in after-market trading, reflecting routine price fluctuations. The asset remains above its 20-day moving average.

29 cze 2026, 23:56 UTC

Skyworks Solutions Inc. shares are lower in after-market hours, continuing to trade below their 20-day moving average amid a trend of lower closes.

29 cze 2026, 23:52 UTC

Japan's Industrial Production Expected to Rise 1.1% in May 2026 Amidst Market Volatility and Uncertainties

29 cze 2026, 23:52 UTC

Japan's May unemployment rate holds steady at 2.5%, aligning with market expectations and reflecting labor market stability.

29 cze 2026, 23:52 UTC

Brazil's S&P Global Services PMI release on July 3, 2026, expected to show continued challenges in the services sector amid stagnant demand and rising inflation pressures.

29 cze 2026, 23:52 UTC

U.S. Initial Jobless Claims Expected at 220,000 Amid Positive Labor Market Sentiment Ahead of July Release

29 cze 2026, 23:52 UTC

U.S. JOLTs Job Openings Report Set for June 30, Forecasting 7.3 Million Positions Amid Optimistic Employment Growth Sentiment

29 cze 2026, 23:52 UTC

ECB Forum on Central Banking to Address Interest Rate Policies Amid Cautious Investor Sentiment and Geopolitical Tensions

29 cze 2026, 23:52 UTC

Social Media

Microsoft shares are higher in after-market trading amid strong interest in cloud and AI infrastructure, despite a legal challenge over copyright infringement.

29 cze 2026, 23:51 UTC

U.S. equity markets show mixed performance amid cautious optimism from U.S.-Iran talks and anticipation of key economic data, including Non-Farm Payrolls.

29 cze 2026, 23:51 UTC

Global equity markets show mixed performance as Asian indices rise on easing U.S.-Iran tensions, while European stocks decline ahead of key U.S. economic data releases.

29 cze 2026, 23:51 UTC

European equity markets show mixed results amid geopolitical tensions and economic uncertainty, with improved Euro Area consumer confidence but declining UK mortgage approvals.

29 cze 2026, 23:51 UTC

Asia equity markets mixed as U.S.-Iran talks boost sentiment, while European indices decline ahead of central bank discussions.

29 cze 2026, 23:51 UTC

ETF Constituents

The Consumer Staples Select Sector SPDR Fund is higher in after-market trading, with Costco and Walmart among the top contributors to performance.

29 cze 2026, 23:51 UTC

Cognizant Technology Solutions shares are higher in after-market trading, reflecting positive sentiment from broader technology gains and recent geopolitical developments.

29 cze 2026, 23:46 UTC

United States Copper Index Fund shows modest gains in after-market trading. The asset fluctuated between a low of -1.07% and a high of 0.59%.

29 cze 2026, 23:46 UTC

T-Mobile US Inc. shares traded roughly flat in after-market hours, influenced by broader gains in technology stocks and a recovery in major averages.

29 cze 2026, 23:41 UTC

Correlated Moves
ETF Constituents

During after-market hours, GDX traded near unchanged, reflecting contributions from Newmont Corporation and Wheaton Precious Metals amid a modest rise in gold prices.

29 cze 2026, 23:41 UTC

iShares TIPS Bond ETF is lower in after-market hours, continuing a decline since Monday's close amid unusual volatility, without any specific news identified.

29 cze 2026, 23:41 UTC

Kraft Heinz Co shares are lower in after-market hours. No specific news was identified to explain the decline, despite recent higher closes.

29 cze 2026, 23:41 UTC

Macro News
Correlated Moves

Bitcoin is trading higher amid eased geopolitical tensions between the U.S. and Iran, reflecting positive sentiment in the cryptocurrency market.

29 cze 2026, 23:31 UTC

ETF Constituents

iShares MSCI Germany ETF declines after market close, impacted by EUR/USD rates and SAP's performance. The asset remains below its 20-day moving average.

29 cze 2026, 23:31 UTC

Verisk Analytics Inc shares are higher in after-market hours, reaching near the upper end of their one-month range amid cautious market optimism and geopolitical developments.

29 cze 2026, 23:31 UTC

Japan's Household Spending Report on July 6, 2026, Anticipated Amid Strong Retail Growth and Currency Concerns.

29 cze 2026, 23:31 UTC

Japan's Household Spending Report Set for July 6, Amidst Strong Retail Sales and Yen Decline Concerns.

29 cze 2026, 23:31 UTC

Shares of Fiserv Inc. are higher in after-market trading, despite earlier declines. Investor sentiment is influenced by geopolitical developments and cautious optimism in the market.

29 cze 2026, 23:31 UTC

Macro News
ETF Constituents

Energy Select Sector SPDR Fund rises after Gulfport Energy's $83 million acquisition and a decline in the U.S. Dollar Index during after-market trading.

29 cze 2026, 23:31 UTC

News
Social Media

Comcast shares are higher in after-market trading amid reports of a potential expansion into video games and plans for AI-focused data centers.

29 cze 2026, 23:26 UTC

MercadoLibre Inc. shares are trading higher in after-market hours, influenced by cautious optimism surrounding U.S.-Iran negotiations and broader market sentiment.

29 cze 2026, 23:26 UTC

Correlated Moves
ETF Constituents

Digital Realty Trust's decline led to little change in VNQ after-hours.

Peer Comparison

Price change

Voyager Therapeutics Inc Forecast

Price Target

By TipRanks

374.86% upside

12 Months Forecast

Average 17 USD  374.86%

High 25 USD

Low 8 USD

Based on 6 Wall Street analysts offering 12 month price targets forVoyager Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

6 ratings

6

Buy

0

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Voyager Therapeutics Inc

Voyager Therapeutics, Inc., a biotechnology company, focuses on the treatment of gene therapy and neurology diseases. The company's lead clinical candidate is VY-TAU01, an anti-tau antibody program for the treatment of alzheimer's disease. Its product pipeline includes superoxide dismutase 1 silencing gene therapy, which is in preclinical trial for the treatment of amyotrophic lateral sclerosis; tau silencing gene therapy, which is in preclinical trial for the treatment of alzheimer's disease; and vectorized anti-amyloid antibody, a gene therapy targeting anti-amyloid for the treatment of alzheimer's disease and is in preclinical trial. In addition, the company develops VY-FXN01, which is in preclinical trial to treat friedreich's ataxia; and GBA1 gene replacement to treat parkinson's disease and is in preclinical trial. Further, it provides research program for the treatment of Huntington's disease. The company has collaboration and license agreements with Alexion; AstraZeneca Rare Disease; Novartis Pharma AG; Neurocrine Biosciences, Inc; and Sangamo Therapeutics, Inc. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.
help-icon Live chat